[1] |
LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong.
One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212.
|
[2] |
MENG Kangkang, LIU Saiyue.
After-marketing safety of coenzyme Q10 for injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 795-798.
|
[3] |
LIU Jing, XIA Liang, ZHANG Shijie.
Pharmaceutical care of a patient with acute pancreatitis complicated with multiple drug allergy undergoing drug stimulation test
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 822-824.
|
[4] |
CHEN Cheng, DENG Li, LIU Songqing, DU Qian, XI Xin.
Analysis of reports of allergic shock in Chongqing between 2015 and 2020
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 460-464.
|
[5] |
YAO Yu, LI Yuanyuan, WEI Xu, XIE Yanming, WANG Zhifei, GAO Minghui.
Influencing factors of suspected allergic reactions related to cervus and cucumis polypeptide for injection in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 740-743.
|
[6] |
YI Yan, TIAN Jingzhuo, LI Chunying, ZHAO Yong, LIANG Aihua.
Pesudoallergic reactions during post-marketing non-clinical safety reevaluation of traditional Chinese medicine injections
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 185-188.
|
[7] |
LIU Chun, WANG Jucai, HUANG Yuchang, YE Xiaoqing, ZHAO Yingshu, ZHAN Meimei, WANG Chen.
Allergic test of azithromycin for injection in guinea pigs in non-clinical safety evaluation
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1161-1164.
|
[8] |
XU Xianxing, YANG Jingwen, MIAO Huiqing.
Potential Risks of Salviae Miltiorrhizae and Ligustrazine Injection
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 575-578.
|
[9] |
FU Hong, RONG Youhe.
One Case of Severe Adverse Drug Reactions Induced by rt-PA and Literature Analysis
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(12): 1198-1200.
|
[10] |
ZHANG Baiyu, XIE Yanming, LIU Huan, SUN Linxi, ZHUANG Yunni.
Influencing Factors of Suspected Allergic Reactions Caused by Ciwujia Injection Based on Prescription Sequence Analysis and Nested Case-control Design
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(10): 956-959.
|
[11] |
QIN Xueying, SUN Linxi, XIE Yanming, LYU Jian, ZHANG Cheng, XIE Yuting, GUO Peng.
Influencing Factors of Suspected Allergic Reactions Caused by Yinzhihuang Granules in the Real World
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(10): 936-939.
|
[12] |
XUE Jing, GAO Min, PAN Ying, LI Xiaoyan.
Clinical Analysis and Countermeasures of Oxaliplatin-induced Allergic in Our Hospital
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(6): 361-365.
|
[13] |
SHEN Xiaohua, HE Jianping, CHANG Hongjian, LIN Qiang.
185 Cases of Adverse Drug Reactions Indued by Propylgallate Injection
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(12): 900-903.
|
[14] |
LI Min, ZHONG Qiaoni, ZHAO Li, LAN Lulu, LIU Dong, ZHANG Chengliang.
Literature analysis of Oxaliplatin Allergic Reactions in Chinese patients
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(11): 798-802.
|
[15] |
WANG Tao, WU Guizhi, DONG Duo.
Analysis and Consideration on Risk of Bromhexine Hydrochloride Injection
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(3): 171-173.
|